Clinical characteristics of over-the-counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers.
addiction
clinical characteristics
drug abuse
drug dependence
over-the-counter drug users
Journal
Neuropsychopharmacology reports
ISSN: 2574-173X
Titre abrégé: Neuropsychopharmacol Rep
Pays: United States
ID NLM: 101719700
Informations de publication
Date de publication:
01 Feb 2024
01 Feb 2024
Historique:
revised:
19
12
2023
received:
02
10
2023
accepted:
30
12
2023
medline:
1
2
2024
pubmed:
1
2
2024
entrez:
1
2
2024
Statut:
aheadofprint
Résumé
To examine the clinical characteristics of over-the-counter (OTC) drug abusers in psychiatric practice in Japan. We examined the attributes, ICD-10 subcategory, and comorbid mental disorders of patients who mainly abuse OTC products and compared the clinical characteristics of single product and multiple products abusers, using the database of the "2022 Nationwide Mental Hospital Survey of Drug-related Disorders." Among the 2468 subjects included in this survey, 273 (11.1%) used OTC products as main drugs. Of these, 209 (78.3%) and 58 (21.7%) were classified into the single product group and the multiple products group, respectively. Six were excluded for unknown ingredients. By comparing these groups, we found that many of the multiple products group consisted of young women who were recently treated for drug problems. Many subjects in the group also had a short treatment period. No differences were observed between the groups regarding the ICD-10 F1 subcategory, but many subjects in the multiple products group fulfilled the criteria of F6 "disorders of adult personality and behavior." OTC products are easily accessible drugs of abuse for young women in Japan. The results of this study indicate the necessity to reconsider the educational approach for preventing drug abuse, which has focused on illicit drugs. The study also indicates that some OTC products, which contain ingredients banned overseas due to their harmful effects, are still sold in Japan and that abusers for those products exist. Measures by the government are considered urgently needed.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.
Références
Hughes L, Whittlesea C, Luscombe D. Patients' knowledge and perceptions of the side-effects of OTC medication. J Clin Pharm Ther. 2002;27:243-248.
Raynor D, Blenkinsopp A, Knapp P, Grime J, Nicolson D, Pollock K, et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess. 2007;11:1-160.
Bond CM, Bradley C. Over the counter drugs: the interface between the community pharmacist and patients. Br Med J. 1996;312:758-760.
Cooper RJ. ‘I can't be an addict. I am’ over-the-counter medicine abuse: a qualitative study. BMJ Open. 2013;3:e002913.
Schifano F, Chiappini S, Miuli A, Mosca A, Santovito MC, Corkery JM, et al. Focus on over-the-counter drugs' misuse: a systematic review on antihistamines, cough medicines, and decongestants. Front Psych. 2021;12:657397.
Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the future national results on adolescent drug use: overview of key findings, 2009 (NIH publication No. 10-7583). Bethesda, MD: National Institute on Drug Abuse; 2010.
Substance abuse and mental health services administration [SAMHSA] results from the 2008 National Survey on drug use and health (NSDUH): National Findings, 2009.
The National Institute on Drug Abuse at the National Institutes of Health. Monitoring the future. National Survey on drug use. 1975-2022.
Hong Kong SAR Government Narcotics Division, Security Bureau. The 2008/09 survey of drug use among students. [cited 2011 Sep 11]. Available from http://www.nd.gov.hk/en/survey_of_drug_use.htm
Benotsch EG, Koester S, Martin AM, Cejka A, Luckman D, Jeffers AJ. Intentional misuse of over-the-counter medications, mental health, and polysubstance use in young adults. J Community Health. 2014;39:688-695.
Matsumoto T, Usami T, Funada D, Okita K, Makino E, Yamamoto T. Survey of drug-related psychiatric disorders in psychiatric hospitals in Japan. Health Labour Research Grant by Ministry of Health and Welfare, Research on Pharmaceutical and Medical Regulatory Science (Principal Investigator, Simane T). 2021. p. 41-104 (in Japanese).
Ookura R, Mino K, Ogata M. Clinical characteristics of patients with psychotropic drug overdose admitted to the emergency department. Acute Med Surg. 2008;19:901-913.
Tarui T, Yoshikawa K, Miyakuni Y, Kaita Y, Tamada N, Matsuda T, et al. Independent risk factors for a complicated hospital course in intensive care unit overdose patients. Acute Med Surg. 2015;2:98-104.
Hashimoto T, Kaneda Y, Ozaki A, Hori A, Tsuchiya T. Eleven-year trend of drug and chemical substance overdose at a local emergency hospital in Japan. Cureus. 2022;14:e32475.
Hockenhull J, Wood DM, Fonseca F, Guareschi M, Scherbaum N, Iwanicki JL, et al. The association between the availability of over the counter codeine and the prevalence of non-medical use. Eur J Clin Pharmacol. 2022;78:1011-1018.
Ministry of Health, Labour and Welfare: The Survey of Pharmaceutical Marketing System [Aug; 2021]. 2021 (in Japanese).
Internet sales of over-the-counter drugs. Tokyo: Ministry of Health, Labour and Welfare, Ministry of Health, Labour and Welfare; 2021. (in Japanese).
Cooper RJ. Over-the-counter medicine abuse - a review of the literature. J Subst Use. 2013;18:82-107.
Gracious B, Abe N, Sundberg J. The importance of taking a history of over-the-counter medication use: a brief review and case illustration of “PRN” antihistamine dependence in a hospitalized adolescent. J Child Adolesc Psychopharmacol. 2010;20:521-524.
McAvoy BR, Dobbin MD, Tobin CL. Over-the-counter codeine analgesic misuse and harm: characteristics of cases in Australia and New Zealand. N Z Med J. 2011;124:29-33.
NIDA. National Institute of health (NIH). Research Report Series Prescription Drug Abuse National Institute on Drug Abuse; 2011.
Schifano F, Chiappini S. Is there such a thing as a ‘lope’ dope? Analysis of loperamide-related European medicines agency (EMA) pharmacovigilance database reports. PLoS ONE. 2018;13:e0204443.
Gittins R, Missen L, Maidment I. Misuse of over the counter and prescription only medication by adults accessing specialist treatment services in the UK: a narrative synthesis. Subst Abus. 2022;16:11782218221111833.
Lam LC, Lee DT, Shum PP, Chen CN. Cough mixture misuse in Hong Kong - an emerging psychiatric problem? Addiction. 1996;91:1375-1378.
Mattoo SK, Basu D, Sharma A, Balaji M, Malhotra A. Abuse of codeine-containing cough syrups: a report from India. Addiction. 1997;92:1783-1787.
Lalwani K, Whitehorne-Smith P, Walcott G, McLeary JG, Mitchell G, Abel W. Prevalence and sociodemographic factors associated with polysubstance use: analysis of a population-based survey in Jamaica. BMC Psychiatry. 2022;22:513.
Martinotti G, Carli V, Tedeschi D, di Giannantonio M, Roy A, Janiri L, et al. Mono- and polysubstance dependent subjects differ on social factors, childhood trauma, personality, suicidal behaviour, and comorbid Axis I diagnoses. Addict Behav. 2009;34:790-793.
Matsumoto T, Usami T, Funada D, et al. Survey of drug-related psychiatric disorders in psychiatric hospitals in Japan. Health Labour Research Grant by Ministry of Health and Welfare, Research on Pharmaceutical and Medical Regulatory Science (Principal Investigator, Simane T); 2023 (in Japanese).
McCabe SE, Cranford JA, Morales M, Young A. Simultaneous and concurrent polydrug use of alcohol and prescription drugs: prevalence, correlates, and consequences. J Stud Alcohol. 2006;67:529-537.
Zamboni L, Portoghese I, Congiu A, Zandonai T, Casari R, Fusina F, et al. Polysubstance use patterns among high dose benzodiazepine users: a latent class analysis and differences between male and female use. Front Psych. 2022;13:811130.
Göbel K, Scheithauer H, Bräker AB, Jonkman H, Soellner R. Substance use patterns among adolescents in Europe: a latent class analysis. Subst Use Misuse. 2016;51:1130-1138.
Petrou S, Kupek E. Epidemiological trends and risk factors for tobacco, alcohol and drug use among adolescents in Scotland, 2002-13. J Public Health. 2018;41:62-70.
Rose RA, Evans CB, Smokowski PR, Howard MO, Stalker KL. Polysubstance use among adolescents in a low income, rural community: latent classes for middle-and high-school students. J Rural Health. 2018;34:227-235.
Kokkevi A, Kanavou E, Richardson C, Fotiou A, Papadopoulou S, Monshouwer K, et al. Polydrug use by European adolescents in the context of other problem behaviours. Nordisk Alkohol Nark. 2014;31:323-342.
Kokkevi A, Stefanis N, Anastasopoulou E, Kostogianni C. Personality disorders in drug abusers: prevalence and their association with Axis I disorders as predictors of treatment retention. Addict Behav. 1998;23:841-853.
Feske U, Tarter RE, Kirisci L, Pilkonis PA. Borderline personality and substance use in women. Am J Addict. 2006;15:131-137.
Alegria AA, Blanco C, Petry NM, Skodol AE, Liu SM, Grant B, et al. Sex differences in antisocial personality disorder: results from the National Epidemiological Survey on Alcohol and Related Conditions. Personal Disord. 2013;4:214-222.
Tate AE, Sahlin H, Liu S, Lu Y, Lundström S, Larsson H, et al. Borderline personality disorder: associations with psychiatric disorders, somatic illnesses, trauma, and adverse behaviors. Mol Psychiatry. 2022;27:2514-2521.
González E, Arias F, Szerman N, Vega P, Mesias B, Basurte I. Coexistence between personality disorders and substance use disorder. Madrid study about prevalence of dual pathology. Actas Esp Psiquiatr. 2019;47:218-228.